176 related articles for article (PubMed ID: 36931016)
1. SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer.
Zhang Y; Zhang Q; Han X; Han L; Wang T; Hu J; Li L; Ding Z; Shi X; Qian X
Transl Oncol; 2023 May; 31():101654. PubMed ID: 36931016
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma.
Zou CY; Guan GF; Zhu C; Liu TQ; Guo Q; Cheng W; Wu AH
CNS Neurosci Ther; 2019 Mar; 25(3):333-342. PubMed ID: 30105842
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
4. SLAMF8 Participates in Acute Renal Transplant Rejection
Teng L; Shen L; Zhao W; Wang C; Feng S; Wang Y; Bi Y; Rong S; Shushakova N; Haller H; Chen J; Jiang H
Front Immunol; 2022; 13():846695. PubMed ID: 35432371
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer.
Ma R; Qu X; Che X; Yang B; Li C; Hou K; Guo T; Xiao J; Liu Y
Onco Targets Ther; 2021; 14():3517-3534. PubMed ID: 34103942
[TBL] [Abstract][Full Text] [Related]
6. SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma.
Sugimoto A; Kataoka TR; Ito H; Kitamura K; Saito N; Hirata M; Ueshima C; Takei Y; Moriyoshi K; Otsuka Y; Nishikori M; Takaori-Kondo A; Haga H
Sci Rep; 2020 Feb; 10(1):2505. PubMed ID: 32054954
[TBL] [Abstract][Full Text] [Related]
7.
Zhang Q; Cheng L; Qin Y; Kong L; Shi X; Hu J; Li L; Ding Z; Wang T; Shen J; Yang Y; Yu L; Liu B; Liu C; Qian X
Clin Transl Immunology; 2021; 10(10):e1347. PubMed ID: 34729183
[TBL] [Abstract][Full Text] [Related]
8. Combined deficiency of SLAMF8 and SLAMF9 prevents endotoxin-induced liver inflammation by downregulating TLR4 expression on macrophages.
Zeng X; Liu G; Peng W; He J; Cai C; Xiong W; Chen S; Yang M; Dong Z
Cell Mol Immunol; 2020 Feb; 17(2):153-162. PubMed ID: 30552382
[TBL] [Abstract][Full Text] [Related]
9. SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis.
Sugimoto A; Kataoka TR; Ueshima C; Takei Y; Kitamura K; Hirata M; Nomura T; Haga H
Exp Dermatol; 2018 Jun; 27(6):641-646. PubMed ID: 29498772
[TBL] [Abstract][Full Text] [Related]
10. SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.
Li T; Yan Z; Wang W; Zhang R; Gan W; Lv S; Zeng Z; Hou Y; Yang M
Front Mol Biosci; 2021; 8():687319. PubMed ID: 34938771
[No Abstract] [Full Text] [Related]
11. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
12. High expression of immune checkpoints is associated with the TIL load, mutation rate and patient survival in colorectal cancer.
Kitsou M; Ayiomamitis GD; Zaravinos A
Int J Oncol; 2020 Jul; 57(1):237-248. PubMed ID: 32468013
[TBL] [Abstract][Full Text] [Related]
13. Knockout of SLAMF8 attenuates collagen-induced rheumatoid arthritis in mice through inhibiting TLR4/NF-κB signaling pathway.
Qin W; Rong X; Yu C; Jia P; Yang J; Zhou G
Int Immunopharmacol; 2022 Jun; 107():108644. PubMed ID: 35259711
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
16. Integrated Analysis of Expression and Prognostic Values of Acyl-CoA Dehydrogenase short-chain in Colorectal Cancer.
Wu Q; Yan T; Chen Y; Chang J; Jiang Y; Zhu D; Wei Y
Int J Med Sci; 2021; 18(16):3631-3643. PubMed ID: 34790035
[No Abstract] [Full Text] [Related]
17. CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer.
Wang X; Zhang Y; Song N; Li K; Lei S; Wang J; Wang Z; Zhang W
Heliyon; 2023 May; 9(5):e15535. PubMed ID: 37144183
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects.
Makaremi S; Asadzadeh Z; Hemmat N; Baghbanzadeh A; Sgambato A; Ghorbaninezhad F; Safarpour H; Argentiero A; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572263
[TBL] [Abstract][Full Text] [Related]
19. SLAMF8 promotes the proliferation and migration of synovial fibroblasts by regulating the ERK/MMPs signalling pathway.
Liu J; Huang Y; Zeng J; Chen C; Li P; Ning Q; Guan X; Li L
Autoimmunity; 2022 Aug; 55(5):294-300. PubMed ID: 35506438
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Model of Colorectal Cancer Constructed by Eight Immune-Related Genes.
Wen S; He L; Zhong Z; Mi H; Liu F
Front Mol Biosci; 2020; 7():604252. PubMed ID: 33330631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
